Chengdu Kanghong Pharmaceutical Group's low P/E is maintaine...
Chengdu Kanghong Pharmaceutical Group's low P/E is maintained as investors find its earnings growth forecasts lower than market expectations. Lack of significant growth potential might continue to suppress share price.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more